Usefulness of B-type natriuretic peptide (BNP) as a screen for left ventricular abnormalities in diabetes mellitus

Diabetes and Metabolism

Volumn 30, Issue 4, 2004, Pages 381-386

  Cosson, S ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

B type natriuretic peptide; Diabetes mellitus; Diabetic cardiomyopathy; Heart failure; Ventricular function

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NEUROHORMONE;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC VALUE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; PROTEIN BLOOD LEVEL; REVIEW; SCREENING TEST;

EID: 4644240821     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70132-5     Document Type: Article

References (50)

1. Butler RA, MacDonald TM, Struthers AD, Morris AD. The clinical implications of diabetic heart disease. Eur Heart J, 1998, 19, 1617-27.
2. Devereux RB, Roman MJ, Paranicas M, et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation, 2000, 101, 2271-6.
3. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation, 1999, 100, 1134-46.
4. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branvvood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol, 1972, 30, 595-602.
5. Struthers AD, Morris AD. Screening for and treating left-ventricular abnormalities in diabetes melhtus: a new way of reducing cardiac deaths. Lancet, 2002, 359, 1430-2.
6. McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet, 1998, 351, 9-13.
7. Yasumoto K, Takata M, Ueno H, Tomita S, Tomoda F, Inoue H. Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension. Am J Hypertens, 1999, 12, 921-4.
8. de Lemos JA, Morrow DA. Brain natriuretic peptide measurement in acute coronary syndromes: ready for clinical application? Circulation 2002, 106, 2868-70.
9. Epshteyn V, Morrison K, Krishnaswamy P, et al. Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care, 2003, 26, 2081-7.
10. Murdoch DR, Byrne J, Morton JJ, et al. Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice. Heart, 1997, 78, 594-7.
11. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation, 1994, 90, 195-203.
12. Kinnunen P, Vuolteenaho O, Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology, 1993, 132, 1961-70.
13. Vogeser M, Jacob K. B-type natriuretic peptide (BNP)-validation of an immediate response assay. Clin Lab, 2001, 47, 29-33.
14. Hughes D, Talwar S, Squire IB, et al. An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction. Clin Sci, 1999, 96, 373-80.
15. Buckley MG, Markandu ND, Miller MA, Sagnella GA, MacGregor GA. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens, 1993, 7, 245-50.
16. Nishikimi T, Yoshihara F, Morimoto A, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension, 1996, 28, 22-30.
17. Suzuki M, Yamamoto K, Watanabe S, Iwata T, Hamada M, Hiwada K. Association between elevated brain natriuretic peptide levels and the development of left ventricular hypertrophy in patients with hypertension. Am J Med, 2000, 108, 627-33.
18. Kohno M, Horio T, Yokokawa K, et al. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor. Am J Med, 1995, 98, 257-65.
19. Lee SC, Stevens TL, Sandberg SM, et al. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure. J Card Fail 2002, 8, 149-54.
20. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002, 347, 161-7.
21. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation, 2002, 106, 416-22.
22. Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997, 350, 1349-53.
23. McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet, 1998, 351, 9-13.
24. Smith H, Pickering RM, Struthers AD, et al. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. BMJ, 2000, 320, 906-8.
25. Vasan RS, Benjamin EJ, Larson MG, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA, 2002, 288, 1252-9.
26. Luchner A, Burnett JC Jr, Jougasaki M, et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens, 2000, 18, 1121-8.
27. Yu CM, Sanderson JE, Shum IOL, et al. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Eur Heart J, 1996, 17, 1694-702.
28. Lang CC, Prasad N, McAlpine HM, Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J, 1994, 127, 1635-6.
29. Krishnaswamy P, Lubien E, Clopton P, et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med, 2001, 111, 274-9.
30. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation, 2002, 105, 595-601.
31. Maisel AS, McCord J, Nowak RM, et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. J Am coll Cardiol, 2003, 41, 2010-7.
32. Cosson S, Kevorkian JP, Mauvais-Jarvis F, et al. Brain natriuretic peptide (BNP) and Left ventricular diastolic dysfunction in normotensive, asymptomatic patients with type 2 diabetes mellitus [abstract]. Diabetes, 2003, 52, A468.
33. Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Colch), 1995, 88, 551-6.
34. Kikuta K, Yasue H, Yoshimura M, et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J, 1996, 132, 101-7.
35. Tateishi J, Masutani M, Ohyanagi M, Iwasaki T. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol, 2000, 23, 776-80.
36. De Lemos J, Morrow D, Bentley J, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med, 2001, 345, 1014-21.
37. Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation, 1993, 88, 82-91.
38. Omland T, Aakvaag A, Bonarjee VVS, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic dysfunction and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation, 1996, 93, 1963-9.
39. de Lemos JA, Morrow DA. Brain natriuretic peptide measurement in acute coronary syndromes: ready for clinical application? Circulation 2002, 106, 2868-70.
40. Nagaya N, Nishikimi T, Okano Y, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998, 31, 202-8.
41. Bando M, Ishii Y, Sugiyama Y, Kitamura S. Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale. Respir Med, 1999, 93, 507-14.
42. Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation, 2002, 106, 92-9.
43. Matsuo K, Nishikimi T, Yutani C, et al. Diagnostic value of plasma levels of brain natriuretic peptide in arrhythmogenic right ventricular dysplasia. Circulation, 1998, 98, 2433-40.
44. Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation, 2003, 107, 2545-7.
45. Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo F. Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol, 1995, 44, 861-4.
46. Haug C, Metzele A, Steffgen J, Grunert A. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure. Horm Metab Res, 1994, 26, 246-9.
47. Zoccali C, Mallamaci F, Benedetto FA, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol, 2001, 12, 1508-15.
48. Luchner A, Burnett JC Jr, Jougasaki M, et al. Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study. J Am Coll Cardiol, 1998, 32, 1839-44.
49. Wang TJ, Larson MG, Levy D, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol, 2002, 90, 254-8.
50. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol, 2002, 40, 976-82.